NAPPI, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.429
AS - Asia 8.303
EU - Europa 6.249
SA - Sud America 1.363
AF - Africa 153
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 9
Totale 25.523
Nazione #
US - Stati Uniti d'America 9.245
CN - Cina 4.375
SG - Singapore 1.917
IE - Irlanda 1.517
BR - Brasile 1.139
HK - Hong Kong 1.054
RU - Federazione Russa 850
UA - Ucraina 802
DE - Germania 712
FI - Finlandia 699
IT - Italia 666
VN - Vietnam 445
SE - Svezia 355
GB - Regno Unito 297
FR - Francia 104
AR - Argentina 93
IN - India 93
CA - Canada 85
MX - Messico 60
NL - Olanda 56
ZA - Sudafrica 56
BD - Bangladesh 44
ID - Indonesia 43
IQ - Iraq 43
JP - Giappone 41
EC - Ecuador 40
PL - Polonia 38
ES - Italia 28
IR - Iran 27
AT - Austria 25
TR - Turchia 24
AE - Emirati Arabi Uniti 23
MA - Marocco 23
CO - Colombia 22
ET - Etiopia 22
PK - Pakistan 20
BE - Belgio 19
CL - Cile 18
PY - Paraguay 18
KE - Kenya 17
UZ - Uzbekistan 16
SA - Arabia Saudita 15
AU - Australia 13
LT - Lituania 13
JO - Giordania 12
AZ - Azerbaigian 11
PH - Filippine 11
KR - Corea 10
VE - Venezuela 10
DO - Repubblica Dominicana 9
IL - Israele 9
PE - Perù 9
KG - Kirghizistan 8
KZ - Kazakistan 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
EU - Europa 7
UY - Uruguay 7
AM - Armenia 6
CR - Costa Rica 6
DZ - Algeria 6
HN - Honduras 6
MY - Malesia 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BO - Bolivia 5
EG - Egitto 5
HU - Ungheria 5
NP - Nepal 5
OM - Oman 5
TW - Taiwan 5
CH - Svizzera 4
DK - Danimarca 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
PS - Palestinian Territory 4
TN - Tunisia 4
AL - Albania 3
KH - Cambogia 3
LU - Lussemburgo 3
MD - Moldavia 3
MU - Mauritius 3
NO - Norvegia 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
AD - Andorra 2
BS - Bahamas 2
BW - Botswana 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
MG - Madagascar 2
MN - Mongolia 2
NI - Nicaragua 2
RS - Serbia 2
SR - Suriname 2
Totale 25.489
Città #
Dublin 1.513
Chandler 1.351
Jacksonville 1.121
Hong Kong 1.047
Nanjing 1.025
Dallas 892
Singapore 761
Ashburn 718
Beijing 581
Boardman 497
Nanchang 436
Princeton 369
Lawrence 337
Shenyang 291
Hebei 288
Changsha 279
Wilmington 278
Los Angeles 255
Jiaxing 242
Medford 233
Redondo Beach 186
Tianjin 180
Ho Chi Minh City 173
Helsinki 165
Moscow 158
Hangzhou 145
Buffalo 142
Ann Arbor 139
Munich 120
Hanoi 115
São Paulo 109
New York 107
Milan 104
Shanghai 103
Woodbridge 87
Norwalk 58
Seattle 51
Turku 51
Pavia 49
Falkenstein 47
Chicago 45
Brooklyn 42
Fairfield 39
Stockholm 39
Montreal 38
Houston 37
Tokyo 36
Rio de Janeiro 35
Warsaw 34
Nuremberg 32
Guangzhou 31
Rome 31
Santa Clara 31
Des Moines 29
Johannesburg 27
Orem 27
Belo Horizonte 26
Chennai 26
The Dalles 26
Verona 26
Curitiba 25
San Francisco 25
Boston 24
Kunming 24
London 23
Denver 22
Poplar 21
Falls Church 20
Zhengzhou 20
Atlanta 19
Brasília 19
Brussels 19
Jinan 19
Amsterdam 18
Varese 18
Gallarate 17
Guayaquil 17
Toronto 17
Aksum 16
Baghdad 16
Florence 16
Haiphong 16
Nairobi 16
Ningbo 16
Phoenix 16
Tashkent 16
Washington 16
Goiânia 15
Mexico City 15
Orange 15
Rozzano 14
Shenzhen 14
Auburn Hills 13
Biên Hòa 13
Campinas 13
Da Nang 13
Quito 13
Secaucus 13
Amman 12
Bologna 12
Totale 16.146
Nome #
Cellule staminali mesenchimali da liquido follicolare ovarico umano: caratterizzazione morfologica e funzionale 273
Advances in pharmacotherapy for treating female sexual dysfunction 189
Aging and sexuality in women 143
HPV infection inhibits aquaporin-mediated hydrogen peroxide elimination and affects human sperm function 132
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 129
Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections 128
Aspetti dietetico nutrizionali dell'infertilità femminile 123
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 122
Acute stress- or lipopolysaccharide-induced corticosterone secretion in female rats is independent of the oestrous cycle. 120
2016 IMS Recommendations on womens midlife health and menopause hormone therapy 117
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. 115
Functional hypothalamic amenorrhea and dietary intervention: A systematic review to guide further research in amenorrheic women without overt eating disorder 113
Correlation between human immunodeficiencyvirus type 1 levels and cytokine profile into thecervicovaginal secretions of a female cohort 113
Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy 112
Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. 109
COMPARISON OF DIFFERENT PROTOCOLS FOR HUMAN SPERM CRYOPRESERVATION: ULTRASTRUCTURAL, MOLECULAR AND CYTOMETRIC ANALYSIS 109
Blood cell mitochondrial DNA content and premature ovarian aging 108
Dietary intakes in infertile women a pilot study 108
Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval 105
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. 105
Dietary under-reporting in women affected by Polycystic Ovary Syndrome: A Pilot Study. 105
Effects of an estrogen-free, desogestrel-containing oralcontraceptive in women with migraine with aura: a prospective diary-based pilotstudy. 104
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 104
Time for a consensus conference on pain in neurorehabilitation 103
Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. 101
Sexual Function and Distress in Women Treated for PrimaryHeadaches in a Tertiary University Center. 100
3-D volumetric and vascular analysis of the urethrovaginal space in young women with or without vaginal orgasm. 98
Electrical stimulation (ES) in the management of sexual pain disorders 98
Aging female brain: is there a change of adaptive stress? 98
Stress and Autonomic Nervous System 97
Clitoral artery blood flow in healthy young women: preliminary report on menstrual cycle and hormonal contraception 96
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 96
Eating disorders and Axis I psychiatric comorbidity in amenorrheic women. 95
Aging female brain: is there a change of adaptive stress? 95
Oral D-mannose in recurrent urinary tract infections in women: A pilot study 95
HPV Infection Affects Human Sperm Functionality by Inhibition of Aquaporin-8 92
Management of hypoactive sexual desire disorder in women: current and emerging therapies. 92
Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. 91
Medical Treatment of Female Sexual Dysfunction 91
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women 90
Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. 90
In-vitro culture system for mesenchymal progenitor cells derived from waste human ovarian follicular fluid. 90
Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS) 90
VULVODYNIA, VULVAR VESTIBULITIS: ETIOLOGY, DIAGNOSIS AND CLINICAL EVALUATION 89
Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL) 89
Bone mass and long-term monophasic oral contraceptive treatment in young women. 88
Follicular fluid putative mesenchymal stem cells (FF-MSC) release E2 and P in vitro 87
Pituitary and ovarian interleukin-1 alpha content changes according to estrous cycle and acute stress exposure. 86
PCOS and urethrovaginal space: 3-D volumetric and vascular analysis. 85
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. 85
ULTRASTRUCTURAL FEATURES OF HUMAN SPERM CELLS CRYOPRESERVED BY DIFFERENT METHODS 85
Sexuality in premature ovarian insufficiency 85
Hormonal management of migraine at menopause. 84
Cognitive function at menopause: neuroendocrine implications for the study of the aging brain. 84
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 84
Gender Differences at the Onset of Autoimmune Thyroid Diseases in Children and Adolescents 84
Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes 83
Migraine and reproductive life. 83
The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. 82
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? 82
Clitoral and labial blood flow in adult women with Turner’s syndrome 81
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 81
Efficacy, tolerability and safety of a new medical device, Monurelle Biogel® vaginal gel, in the treatment of vaginal dryness: A randomized clinical trial in women of reproductive age 81
Ontogeny of the circadian rhythm in medial basal hypothalamic beta-endorphin content in female rat. 81
Vaginal health in the United States 80
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 79
External cephalicversion as a possible treatment of breech presentation 79
Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey 78
Effects of surgical and adjuvant therapies for breast cancer on sexuality,cognitive functions, and body weight. 78
Effect of sex and estrogens on neuronal activation in an animal model of migraine. 78
SEXUAL FUNCTION IN WOMEN WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME 78
Role of testosterone in feminine sexuality 77
New attitudes to sexuality in the menopause: clinical evaluation and diagnosis 77
Association of E2v/dng as contraceptive choice for a better quality of life of women. 77
Oral magnesium successfully relieves premenstrual mood changes. 77
Effects of combined hormonal contraception on health and wellbeing: Women's knowledge in northern Italy. 77
Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. 77
Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer 77
Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. 77
Reproductive life milestones in women with Parkinson's disease 76
Stimulatingeffect of HIV-1 coat protein gp120 on corticotropin-releasing hormone andarginine vasopressin in the rat hypothalamus: involvement of nitric oxide. 76
The American–European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey 76
Markers of local immunity in cervico-vaginal secretions of HIV-infected women: implications for HIV shedding. 76
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 76
Migraine is a risk factor for hypertensive disorders inpregnancy: a prospective cohort study. 75
The role of 3-D ultrasonography in the evaluation of menstrual cycle-related vascularmodifications of the clitoris. A prospective pilot study. 75
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? 75
Neuroendocrine findings in chornic paroxysmal hemicrania and hemicrania continua 75
Plasma Apelin Levels: Relationship with Anthropometry, Body Composition Parameters, and Leptin in a sample of women with menstrual irregularities 75
Cigarette smoking decreases the genital vascularization in younghealthy, eumenorrheic women. 74
Pituitary LH reserve suggests high risk of bulimia in amenorrheic women. 74
Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level. 74
Perineal floor efficiency in sexually potent and impotent men. 74
Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats. 74
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. 74
2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know? 74
Course of primary headaches during hormone replacement therapy. 73
Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide 73
Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithm. 73
Vaginal Health: Insights, Views & Attitudes (VIVA) survey - Canadian cohort. 73
Totale 9.284
Categoria #
all - tutte 124.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.080 0 0 0 0 0 208 11 293 76 241 203 48
2021/20221.262 13 9 17 12 20 24 25 77 90 37 219 719
2022/20234.190 506 274 28 282 453 423 4 238 1.779 29 129 45
2023/20241.499 162 258 69 141 174 325 73 101 16 61 57 62
2024/20254.936 115 423 108 177 98 262 281 341 1.176 215 455 1.285
2025/20266.697 997 881 1.542 1.607 1.494 176 0 0 0 0 0 0
Totale 26.024